Company Filing History:
Years Active: 2021
Title: Innovations of Nicolas Miles in Photoplethysmography
Introduction
Nicolas Miles is an accomplished inventor based in Nottingham, GB. He has made significant contributions to the field of medical technology, particularly through his innovative work in photoplethysmography. His inventions aim to enhance the understanding of blood volume and composition, which can be crucial for various medical applications.
Latest Patents
Nicolas Miles holds a patent for a photoplethysmograph device. This device includes a light source that illuminates a target object. A modulator drives the light source, causing the output intensity to vary based on a modulation signal at a specific frequency. A detector captures the light from the target object and generates an electrical output corresponding to the intensity of the received light. The device features a demodulator with a local oscillator that processes the detector output, producing a demodulated output that is insensitive to any phase difference. This output indicates blood volume as a function of time and/or blood composition. The device can operate in both transmission and reflectance modes, utilizing the green part of the optical spectrum and polarizing filters when in reflectance mode.
Career Highlights
Nicolas Miles is affiliated with the University of Nottingham, where he continues to advance his research and development in medical technologies. His work has garnered attention for its potential applications in healthcare, particularly in non-invasive monitoring techniques.
Collaborations
Nicolas collaborates with notable colleagues, including John Andrew Crowe and Mark Grubb. Their combined expertise contributes to the innovative projects at the University of Nottingham.
Conclusion
Nicolas Miles is a pioneering inventor whose work in photoplethysmography represents a significant advancement in medical technology. His contributions have the potential to improve non-invasive monitoring methods, benefiting healthcare professionals and patients alike.